Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-05-24

Clinical Trial Update: Continuous v Bolus Infusion of Cefazolin During Ventral Hernia Repair [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing continuous infusion versus bolus infusion of cefazolin during ventral hernia repair was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CEFAZOLIN (cefazolin sodium)

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Surgical Site Infections | Phase 4 | Status: WITHDRAWN